Raffaele Pellerito

1.5k total citations
17 papers, 376 citations indexed

About

Raffaele Pellerito is a scholar working on Rheumatology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Raffaele Pellerito has authored 17 papers receiving a total of 376 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Rheumatology, 5 papers in Genetics and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Raffaele Pellerito's work include Rheumatoid Arthritis Research and Therapies (10 papers), Systemic Lupus Erythematosus Research (8 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Raffaele Pellerito is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (10 papers), Systemic Lupus Erythematosus Research (8 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Raffaele Pellerito collaborates with scholars based in Italy, United States and Denmark. Raffaele Pellerito's co-authors include Roberto Caporali, Fabiola Atzeni, Piercarlo Sarzi‐Puttini, Antonio Marchesoni, Guido Rovera, Gabriela Riemekasten, Tifenn Leturcq, Yannick Allanore, Britta Maurer and Valeria Riccieri and has published in prestigious journals such as Gastroenterology, PLoS ONE and Annals of the New York Academy of Sciences.

In The Last Decade

Raffaele Pellerito

16 papers receiving 368 citations

Peers

Raffaele Pellerito
Marion Mehrenberger France
KY Wong China
Michelle Lopes Brazil
Hanxiao You China
Paul Legendre France
Douglas W. Lienesch United States
Avery Maddox United States
Laura Brockwell United Kingdom
Sonal Mehra India
E. Becerra Spain
Marion Mehrenberger France
Raffaele Pellerito
Citations per year, relative to Raffaele Pellerito Raffaele Pellerito (= 1×) peers Marion Mehrenberger

Countries citing papers authored by Raffaele Pellerito

Since Specialization
Citations

This map shows the geographic impact of Raffaele Pellerito's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raffaele Pellerito with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raffaele Pellerito more than expected).

Fields of papers citing papers by Raffaele Pellerito

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raffaele Pellerito. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raffaele Pellerito. The network helps show where Raffaele Pellerito may publish in the future.

Co-authorship network of co-authors of Raffaele Pellerito

This figure shows the co-authorship network connecting the top 25 collaborators of Raffaele Pellerito. A scholar is included among the top collaborators of Raffaele Pellerito based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raffaele Pellerito. Raffaele Pellerito is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Quartuccio, Luca, S. Salvin, Martina Fabris, et al.. (2024). Cost saving and predictive factors of response to rituximab in rheumatoid arthritis, including the IL-6 promoter gene polymorphism. Italian Journal of Public Health. 9(4).
2.
Rossi, Daniela, Savino Sciascia, Irene Cecchi, et al.. (2021). A 3-Year Observational Study of Patients with Progressive Systemic Sclerosis Treated with an Intensified B Lymphocyte Depletion Protocol: Clinical and Immunological Response. Journal of Clinical Medicine. 10(2). 292–292. 6 indexed citations
3.
Bodio, Caterina, C. Grossi, Francesca Pregnolato, et al.. (2020). Personalized medicine in rheumatoid arthritis: How immunogenicity impacts use of TNF inhibitors. Autoimmunity Reviews. 19(5). 102509–102509. 11 indexed citations
4.
Manara, M., Roberto Caporali, Ennio Giulio Favalli, et al.. (2017). Two-year retention rate of golimumab in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis: data from the LORHEN registry.. PubMed. 35(5). 804–809. 21 indexed citations
5.
Buondonno, Ilaria, Guido Rovera, Francesca Sassi, et al.. (2017). Vitamin D and immunomodulation in early rheumatoid arthritis: A randomized double-blind placebo-controlled study. PLoS ONE. 12(6). e0178463–e0178463. 43 indexed citations
6.
Monti, Sara, Catherine Klersy, Roberto Gorla, et al.. (2017). Factors influencing the choice of first- and second-line biologic therapy for the treatment of rheumatoid arthritis: real-life data from the Italian LORHEN Registry. Clinical Rheumatology. 36(4). 753–761. 36 indexed citations
7.
Salaffi, Fausto, Marco Di Carlo, Florenzo Iannone, et al.. (2017). The UltraSound-CLinical ARthritis Activity (US-CLARA) index: Properties of a new composite disease activity index for rheumatoid arthritis. Seminars in Arthritis and Rheumatism. 47(5). 619–629. 7 indexed citations
8.
Favalli, Ennio Giulio, L. Sinigaglia, Andrea Becciolini, et al.. (2017). Two‐year persistence of golimumab as second‐line biologic agent in rheumatoid arthritis as compared to other subcutaneous tumor necrosis factor inhibitors: real‐life data from the LORHEN registry. International Journal of Rheumatic Diseases. 21(2). 422–430. 21 indexed citations
9.
Caporali, Roberto, Antonio Carletto, Fabrizio Conti, et al.. (2017). Using a modified Delphi process to establish clinical consensus for the diagnosis, risk assessment and abatacept treatment in patients with aggressive rheumatoid arthritis.. PubMed. 35(5). 772–776. 2 indexed citations
10.
Varisco, V., Mauro Viganò, Alberto Batticciotto, et al.. (2016). Low Risk of Hepatitis B Virus Reactivation in HBsAg-negative/Anti-HBc–positive Carriers Receiving Rituximab for Rheumatoid Arthritis: A Retrospective Multicenter Italian Study. The Journal of Rheumatology. 43(5). 869–874. 45 indexed citations
11.
12.
Ceccarelli, Fulvia, Carlo Perricone, Francesco Trotta, et al.. (2013). Remission in early, aggressive rheumatoid arthritis: a multicentre prospective observational Italian study ARPA (Artrite Reumatoide Precoce Aggressiva).. PubMed. 31(3). 341–9. 2 indexed citations
13.
Elhaï, Muriel, Marine Meunier, Marco Matucci‐Cerinic, et al.. (2012). Outcomes of patients with systemic sclerosis-associated polyarthritis and myopathy treated with tocilizumab or abatacept: a EUSTAR observational study. Annals of the Rheumatic Diseases. 72(7). 1217–1220. 127 indexed citations
14.
Fabris, Martina, Salvatore De Vita, Elisa Pasini, et al.. (2012). Chlamydophila psittaci subclinical infection in chronic polyarthritis.. PubMed. 29(6). 977–82. 8 indexed citations
15.
D’Amelio, Patrizia, Maria Angela Cristofaro, Lucia D’Amico, et al.. (2010). Iloprost modulates the immune response in systemic sclerosis. BMC Immunology. 11(1). 62–62. 15 indexed citations
16.
Quartuccio, Luca, Sandra Lombardi, Martina Fabris, et al.. (2009). Long‐Term Effects of Rituximab in Rheumatoid Arthritis. Annals of the New York Academy of Sciences. 1173(1). 692–700. 16 indexed citations
17.
Marchesoni, Antonio, N. Battafarano, Marco Arreghini, et al.. (2002). Step‐down approach using either cyclosporin A or methotrexate as maintenance therapy in early rheumatoid arthritis. Arthritis Care & Research. 47(1). 59–66. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marion Mehrenberger Breakdown of academic impact, for papers by KY Wong Breakdown of academic impact, for papers by Michelle Lopes Breakdown of academic impact, for papers by Hanxiao You Breakdown of academic impact, for papers by Paul Legendre Breakdown of academic impact, for papers by Douglas W. Lienesch Breakdown of academic impact, for papers by Avery Maddox Breakdown of academic impact, for papers by Laura Brockwell Breakdown of academic impact, for papers by Sonal Mehra Breakdown of academic impact, for papers by E. Becerra
Rankless by CCL
2026